These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6274563)

  • 1. Factors influencing cardiac hypertrophy in hypertensive patients.
    Ibrahim MM; Madkour MA; Mossallam R
    Clin Sci (Lond); 1981 Dec; 61 Suppl 7():105s-108s. PubMed ID: 6274563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Echocardiographic left ventricular hypertrophy as related to arterial pressure and plasma norepinephrine concentration in arterial hypertension. Reversal by atenolol treatment.
    Corea L; Bentivoglio M; Verdecchia P
    Hypertension; 1983; 5(6):837-43. PubMed ID: 6228528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time course of regression of left ventricular hypertrophy in hypertensive patients treated with atenolol.
    Dunn FG; Ventura HO; Messerli FH; Kobrin I; Frohlich ED
    Circulation; 1987 Aug; 76(2):254-8. PubMed ID: 2955954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Regression of left ventricular mass in arterial hypertension. Efficacy of 3 different treatment protocols].
    González-Juanatey JR; Amaro Cendón A; Calvo Gómez C; Vega Fernández M; García Acuña JM; Virgós Lamela A; Gil de la Peña M
    Med Clin (Barc); 1992 Mar; 98(11):401-4. PubMed ID: 1533259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationships between left ventricular mass and clinical, biohumoral and hemodynamic parameters in human hypertension.
    Volpe M; Trimarco B; Mele A; Cuocolo A; De Luca N; Ricciardelli B; Condorelli M
    Cardiology; 1984; 71(1):1-12. PubMed ID: 6327039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hypertensive cardiopathy. Functional evaluation during isometric effort after regression of left ventricular hypertrophy].
    Nogueira JB; Freitas A; Morais C; Silva D; Esteves J; da Costa JN
    Rev Port Cardiol; 1992 Mar; 11(3):229-38. PubMed ID: 1535203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Left ventricular hypertrophy in hypertension: functional aspects].
    Lombardo M; Zaini G; Colloca W; Belli C
    G Ital Cardiol; 1987 Dec; 17(12):1039-44. PubMed ID: 2972580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relation of hemodynamic load to left ventricular hypertrophy and performance in hypertension.
    Devereux RB; Savage DD; Sachs I; Laragh JH
    Am J Cardiol; 1983 Jan; 51(1):171-6. PubMed ID: 6217738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of antihypertensive therapy on left ventricular mass in elderly patients.
    Schulman SP; Weiss JL; Becker LC; Gottlieb SO; Woodruff KM; Weisfeldt ML; Gerstenblith G
    N Engl J Med; 1990 May; 322(19):1350-6. PubMed ID: 2139175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of actions of irbesartan versus atenolol on cardiac repolarization in hypertensive left ventricular hypertrophy: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation Versus Atenolol (SILVHIA).
    Malmqvist K; Kahan T; Edner M; Bergfeldt L
    Am J Cardiol; 2002 Nov; 90(10):1107-12. PubMed ID: 12423712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue velocity echocardiography shows early improvement in diastolic function with irbesartan and atenolol therapy in patients with hypertensive left ventricular hypertrophy. Results form the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA).
    Müller-Brunotte R; Kahan T; Malmqvist K; Ring M; Edner M
    Am J Hypertens; 2006 Sep; 19(9):927-36. PubMed ID: 16942935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preserved ventricular pump function after a marked reduction of left ventricular mass.
    Ketelhut R; Franz IW; Behr U; Toennesmann U; Messerli FH
    J Am Coll Cardiol; 1992 Oct; 20(4):864-8. PubMed ID: 1356116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac determinants of regression of left ventricular hypertrophy in essential hypertension with antihypertensive treatment.
    Sugishita Y; Iida K; Yukisada K; Ito I
    J Am Coll Cardiol; 1990 Mar; 15(3):665-71. PubMed ID: 2137479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of atenolol on left ventricular hypertrophy and early left ventricular function in essential hypertension.
    Allen JW; Kaiser PJ; Montenegro A
    Am J Cardiol; 1989 Nov; 64(18):1157-61. PubMed ID: 2530892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beneficial effects of one year's treatment with captopril on left ventricular anatomy and function in hypertensive patients with left ventricular hypertrophy.
    Muiesan ML; Agabiti-Rosei E; Romanelli G; Castellano M; Beschi M; Muiesan G
    Am J Med; 1988 Mar; 84(3A):129-32. PubMed ID: 2975462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left ventricular mass in borderline hypertension, assessed by echocardiography. Relationships with resting and stress blood pressure.
    Giaconi S; Palombo C; Marabotti C; Genovesi-Ebert A; Mezzasalma L; Volterrani D; Ghione S
    J Nucl Med Allied Sci; 1989; 33(1):26-31. PubMed ID: 2526204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Determinants for myocardial hypertrophy in mild essential hypertension. The effect of sodium chloride on left-ventricular hypertrophy].
    Schmieder RE; Grube E; Impelmann V; Rüddel H; Schulte W
    Z Kardiol; 1990 Aug; 79(8):557-64. PubMed ID: 2145705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac function as related to adrenergic activity in hypertensive left ventricular hypertrophy.
    Agabiti-Rosei E; Muiesan ML; Romanelli G; Castellano M; Beschi M; Alicandri C; Muiesan G
    J Clin Hypertens; 1987 Jun; 3(2):203-10. PubMed ID: 3039076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regression of left ventricular hypertrophy during combined atenolol and nifedipine treatment.
    Franz IW; Tönnesmann U; Behr U; Ketelhut R
    Drugs; 1988; 35 Suppl 4():39-43. PubMed ID: 2967752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of left ventricular hypertrophy in patients with essential hypertension.
    Glasser SP; Koehn DK
    Clin Cardiol; 1989 Mar; 12(3):129-32. PubMed ID: 2522362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.